Pharvaris N.V. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 76.33 million compared to EUR 42.73 million a year ago. Basic loss per share from continuing operations was EUR 2.27 compared to EUR 1.4 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.9 USD | -0.34% | -4.15% | -32.85% |
05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
05-08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.85% | 1.02B | |
+46.83% | 54.63B | |
-6.51% | 39.92B | |
+37.07% | 38.82B | |
+13.55% | 26.86B | |
-11.17% | 26.22B | |
-21.35% | 18.78B | |
+24.99% | 12.21B | |
+1.02% | 12.16B | |
+25.97% | 11.94B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Pharvaris N.V. Reports Earnings Results for the Full Year Ended December 31, 2022